Skip to content

Effect of Tabashir tablet in treatment of diabetes

Evaluation of the effect of traditional Persian diabetes product (Tabashir tablet) on blood glucose level in patients with type 2 diabetes: a double-blind placebo-controlled clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230307057648N1
Enrollment
106
Registered
2024-01-08
Start date
2024-02-20
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: One 500 mg Tabashir capsule three times a day. . Formulation (in w/w) Tabashir powder 13.2, licorice root solid extract 13.2, lettuce seed 26.5, purslane seed 20, A

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: Uncontrolled type 2 diabetes Age 30-65 years HbA1c greater than 7 and lower than 8.5 Under treatment with oral diabetes medications (one or more drug groups) At least one month after increasing the dose of antidiabetic medicine or prescribing a new antidiabetic medicine

Exclusion criteria

Exclusion criteria: Glomerular filtration rate, lower than 60 ml per minute Serum albumin, lower than 4 g/dL SGOT and SGPT, three times higher than normal level Pregnancy and breastfeeding or intention to become pregnant Taking insulin along with oral diabetes medications

Design outcomes

Primary

MeasureTime frame
Blood sugar. Timepoint: Blood sugar measurement at the beginning of the study (before the start of the intervention) and three months after taking the Tabashir capsule. Method of measurement: Blood test.

Secondary

MeasureTime frame
Lipid profile. Timepoint: At the beginning and end of three months of study. Method of measurement: Blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahbubeh Bozorgi

Shahed University

mahboubehbozorgi@gmail.com+98 21 5521 4060

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026